Home  - Health_Conditions - Respiratory Syncytial Virus

Books Baby Camera Phones Computers Games DVD Electronics Kitchen Magazines Music Garden Software Tools Toys Video Apparel & Accessories Jewelry & Watches Musical Instruments Health & Personal Care Beauty Sports & Outdoors Office Products

e99.com Bookstore

Images

Newsgroups

61-80 of 96    Back | 1  | 2  | 3  | 4  | 5  | Next 20

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Respiratory Syncytial Virus:     more books (64)

Investigational antibody effective against RSV.(Infectious Diseases)(respiratory syncytial virus)(motavizumab): An article from: Pediatric News by Patrice Wendling, 2007-08-01 Respiratory syncytial virus activity--United States, 2004-2005.(Brief Report): An article from: Morbidity and Mortality Weekly Report 21st Century Ultimate Medical Guide to Respiratory Syncytial Virus (RSV) - Authoritative Clinical Information for Physicians and Patients (Two CD-ROM Set) by U.S. Government, 2009-06-14 Palivizumab protection against RSV better in real world than in trials: fewer hospitalizations.(Children's Health)(respiratory syncytial virus): An article from: Family Practice News by Damian McNamara, 2004-07-15 Respiratory syncytial virus immune globulin (AAFP home study self-assessment) by Emily A Dierker, 1996 Study of the antigenicity and immunogenicity of mycoplasma pneumoniae vaccines: (including studies on respiratory syncytial virus and adjuvanting effects of polynucleotides) by Laurence Benfred Senterfit, 1971 BRSV, or bovine respiratory syncytial virus (V-924) by Malcolm Herbert Smith, 1987 RSV burden much worse than previously recognized.(INFECTIOUS DISEASES)(respiratory syncytial virus): An article from: Family Practice News by Mary Ann Moon, 2009-03-01 Studies on respiratory syncytial virus infection (Acta paediatrica Scandinavica) by Bo Berglund, 1967 Respiratory syncytial virus: Child development / James Coplin (Current problems in pediatrics) by Olli Ruuskanen, 1993 The Official Parent's Sourcebook on Respiratory Syncytial Virus by James N. Parker, 1980 Contemporary Diagnosis And Management Of Respiratory Syncytial Virus by Leonard E.; Groothuis, Jessie R. (editors) Weisman, 2000 Controversies in infectious disease: one expert's picks: MRSA, RSV are hot.(Infectious Diseases)(methicillin-resistant Staphylococcus aureus)(respiratory ... virus): An article from: Pediatric News by Heidi Splete, 2004-03-01 Vaccines coming for three important viruses: infectious disease forecast.(Children's Health): An article from: Family Practice News by Heidi Splete, 2004-01-15

lists with details

61. Ribavirin For Respiratory Syncytial Virus Infection Of The Lower Respiratory Tra
    All rights reserved. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract (Cochrane Review). Randolph AG, Wang EEL. ABSTRACT.  
    http://www.update-software.com/abstracts/AB000181.htm
    
    Extractions: From The Cochrane Library, Issue 2, 2004 Ribavirin for respiratory syncytial virus infection of the lower respiratory tract (Cochrane Review) Randolph AG, Wang EEL ABSTRACT Order full review View and/or submit comments What's new in this issue Search abstracts ... Browse by Review Group A substantive amendment to this systematic review was last made on 11 January 2000. Cochrane reviews are regularly checked and updated if necessary. Background: Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infection in infants leading to 100,000 hospitalizations annually. Ribavirin is approved for treatment of these infections, but its use is controversial because of questions on its efficacy, concerns about occupational exposure and its high cost. Objectives: Respiratory syncytial virus (RSV) is a common cause of pneumonia in infants. Ribavirin is the only antiviral therapy available against RSV. The objective of this review was to assess the effects of aerosolized ribavirin for infants with RSV lower respiratory tract infection. Search strategy: We searched MEDLINE from 1975 to 1999, we scanned reference lists of articles, and we contacted experts in the field.

62. Immunoglobulin For Preventing Respiratory Syncytial Virus Infection (Cochrane Re
    All rights reserved. Immunoglobulin for preventing respiratory syncytial virus infection (Cochrane Review). Wang EEL, Tang NK. ABSTRACT.  
    http://www.update-software.com/abstracts/AB001725.htm
    
    Extractions: From The Cochrane Library, Issue 2, 2004 Immunoglobulin for preventing respiratory syncytial virus infection (Cochrane Review) Wang EEL, Tang NK ABSTRACT Order full review View and/or submit comments What's new in this issue Search abstracts ... Browse by Review Group A substantive amendment to this systematic review was last made on 10 March 1999. Cochrane reviews are regularly checked and updated if necessary. Background: Respiratory Syncytial virus, the most important cause of lower respiratory tract infections in infants and young children in industrialized countries, is associated with increased morbidity in premature infants with or without bronchopulmonary dysplasia as well as those with congenital heart disease. Because of observations that lower rates of disease occur immediately after birth, presumably due to vertical transmission of maternal antibody, and animal studies where protection from pneumonia was observed through administration of immune globulin, the efficacy of passive prophylaxis in premature infants has been studied. Objectives: This meta-analysis was performed to assess the effects of polyclonal respiratory syncytial virus hyperimmune globulin or monoclonal antibody in preventing RSV hospitalization, receipt of intensive care, mechanical ventilation, and mortality in those with underlying prematurity, bronchopulmonary dysplasia, or congenital heart disease.

63. BioMed Central | Full Text | Respiratory Syncytial Virus And TNFalpha Induction
    respiratory syncytial virus and TNFalpha induction of chemokine gene expression involves differential activation of Rel A and NFkappaB1 Laura R Carpenter  
    http://www.biomedcentral.com/1471-2334/2/5
    
    Extractions: Background Respiratory syncytial virus (RSV) infection of airway epithelial cells stimulates the expression and secretion of a variety of cytokines including the chemotactic cytokines interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and RANTES (regulated upon activation, normal T cell expressed and secreted). Chemokines are important chemoattractants for the recruitment of distinct sets of leukocytes to airway sites of inflammation. Results We have shown previously that chemokine expression is regulated in airway epithelial cells (A549) in a stimulus-specific manner in part through the redox-responsive transcription factors AP-1 and NF-

64. Entrez PubMed
    Click here to read respiratory syncytial virus infection in adults. Falsey AR, Walsh EE. Rochester General Hospital and University  
    http://www.biomedcentral.com/pubmed/10885982
    
    Extractions: Summary Brief Abstract Citation ASN.1 MEDLINE XML UI List LinkOut Related Articles Cited in Books CancerChrom Links Domain Links 3D Domain Links GEO DataSet Links Gene Links Genome Links GEO Links HomoloGene Links Nucleotide Links OMIM Links PMC Links Cited in PMC PopSet Links Protein Links SNP Links Structure Links UniSTS Links Show: Sort Author Journal Pub Date Text File Clipboard E-mail Order

65. NEJM -- Respiratory Syncytial Virus And Parainfluenza Virus
    Review Article from The New England Journal of Medicine respiratory syncytial virus and Parainfluenza Virus. respiratory syncytial virus.  
    http://content.nejm.org/cgi/content/short/344/25/1917
    
    Extractions: Add to Personal Archive Add to Citation Manager ... Chapters at Harrison's Respiratory syncytial virus (RSV), originally recovered from a colony of chimpanzees with coryza and designated chimpanzee coryza agent, and human parainfluenza virus types 1, 2, 3, and 4 have been known primarily as respiratory pathogens in young children. They are now recognized as important pathogens in adults as well. Adults infected with these viruses tend to have more variable and less distinctive clinical findings than children, and the viral cause of the infection is often unsuspected. The consistency of the annual outbreaks of these agents and the frequency of reinfection suggest that they impose a considerable, but Full Text of this Article Classification and Structure Epidemiologic Features Pathogenesis Effect of Disease in Children and Adults Infections in Immunocompromised Patients Reinfections in Previously Healthy Persons Immunity Diagnosis Prospects for Immunization Prophylaxis with Immune Globulin Therapy Conclusions References This article has been cited by other articles: Iwane, M. K., Edwards, K. M., Szilagyi, P. G., Walker, F. J., Griffin, M. R., Weinberg, G. A., Coulen, C., Poehling, K. A., Shone, L. P., Balter, S., Hall, C. B., Erdman, D. D., Wooten, K., Schwartz, B., for the New Vaccine Surveillance Network, (2004). Population-Based Surveillance for Hospitalizations Associated With Respiratory Syncytial Virus, Influenza Virus, and Parainfluenza Viruses Among Young Children.

66. Entrez PubMed
    Click here to read respiratory syncytial virus infection. respiratory syncytial virus Infections*/immunology; respiratory syncytial virus Infections*/therapy;  
    http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1

67. Entrez PubMed
    Click here to read respiratory syncytial virus and parainfluenza virus. Hall CB. University of Rochester School of Medicine and Dentistry, NY, USA.  
    http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1

68. Respiratory Syncytial Virus (RSV)
    From Newborn Infant Nursing Reviews. respiratory syncytial virus (RSV) Overview, Treatment, and Prevention Strategies. Posted 04/13/2004. Mark J. Polak, MD.  
    http://www.medscape.com/viewarticle/472399

69. Update: Respiratory Syncytial Virus Activity -- United States, 1997-98 Season
    Update respiratory syncytial virus Activity United States, 199798 Season. Appendix N prospects for immunizing against respiratory syncytial virus.  
    http://wonder.cdc.gov/wonder/prevguid/m0050267/m0050267.asp
    
    Extractions: Percentage of specimens testing positive for ... Respiratory syncytial virus (RSV), a common cause of winter outbreaks of acute respiratory disease, results in an estimated 90,000 hospitalizations and 4500 deaths each year from lower respiratory tract disease among infants and young children in the United States (1). Outbreaks occur annually throughout the country (2,3). RSV activity in the United States is monitored by the National Respiratory and Enteric Virus Surveillance System (NREVSS), a voluntary, laboratory-based system. This report summarizes trends in RSV reported by NREVSS for July 1992-June 1997 and presents provisional surveillance results for July-November 1997. These data indicate onset of widespread RSV activity for the 1997-98 season. Since July 1992, a total of 100 clinical and public health laboratories in 47 states have participated in NREVSS and have reported weekly to CDC the number of specimens tested for RSV by the antigen-detection and virus-isolation methods and the number of positive results. RSV activity is considered by NREVSS to have become widespread during the first of 2 consecutive weeks during which at least half of participating laboratories report any RSV detections. This definition generally indicates a mean percentage of specimens positive by antigen detection in excess of 10%.

70. Prevention Guidelines Titles
    Prevention Guidelines. Topic respiratory syncytial virus. Update respiratory syncytial virus Activity United States, 199798 Season; 19971212.  
    http://wonder.cdc.gov/wonder/prevguid/tp_01600.html

71. Respiratory Syncytial Virus (RSV) Drugs Lawsuit Overview - Find Trial Lawyers An
    respiratory syncytial virus (RSV) Drugs Overview respiratory syncytial virus or RSV Drugs Overview - Find Trial Lawyers and Attorneys with Experience in  
    http://www.injuryboard.com/view.cfm/Topic=426
    
    Extractions: June 2, 2004 There were nearly 96,000 vacant nursing positions at nursing homes across the United States in 2002. Vioxx / Rofecoxib Tractor-Trailer Accidents Serzone / Nefazodone Hydrochloride Tort Reform ... Drugs Respiratory Syncytial Virus or RSV Drugs: Overview If you or a family member has been injured, contact a personal injury attorney today. Just fill out InjuryBoard.com's on-line questionnaire and have a personal injury lawyer review your potential personal injury claim - free of charge. Ask an Attorney Respiratory Syncytial Virus (RSV) is a contagious infection that is usually mild in adults and older children, but can be extremely serious in infants, the elderly, and those with compromised immune systems . Over 120,000 infants and young children are hospitalized each year with RSV. RSV affects the lungs and may lead to pneumonia and other lung diseases Click below to learn more about some specific drugs used to treat or prevent RSV. Would you like to use this material on your law firm web site?

72. Respiratory Syncytial Virus Antigens (immunofluorescence)
    Detection of respiratory syncytial virus antigens in cells from nasopharyngeal secretions. Indirect immunofluorescence M. Battaglia, L. Balducci.  
    http://pages2.inrete.it/mbiomed/rsvif.htm
    
    Extractions: PREVIOUS Home Photomicrography Gallery NEXT Detection of respiratory syncytial virus antigens in cells from nasopharyngeal secretions. Indirect immunofluorescence [M. Battaglia, L. Balducci. 1980 - Rapid diagnosis of respiratory syncytial virus infections by immunofluorescence on cell smears from nasopharyngeal secretions. Bollettino dell'Istituto Sieroterapico Milanese

73. AllRefer Health - Respiratory Syncytial Virus (RSV) (RSV)
    respiratory syncytial virus (RSV) (RSV) information center covers causes, prevention, symptoms, diagnosis, treatment, incidence, risk factors, signs, tests  
    http://health.allrefer.com/health/respiratory-syncytial-virus-rsv-info.html
    
    Extractions: AllRefer Channels :: Yellow Pages Reference Health Home ... Contact Us Quick Jump ADD/ADHD Allergies Alzheimer's Disease Arthritis Asthma Back Pain Breast Cancer Cancer Colon Cancer Depression Diabetes Gallbladder Disease Heart Attack Hepatitis High Cholesterol HIV/AIDS Hypertension Lung Cancer Menopause Migraines/Headaches Osteoporosis Pneumonia Prostate Cancer SARS Stroke Urinary Tract Infection 1600+ More Conditions Alternative Medicine Health News Symptoms Guide Special Topics ... Medical Encyclopedia Go To Main Page Alternate Names : RSV Definition Respiratory syncytial virus (RSV) is a very common virus that causes mild cold-like symptoms in adults and older healthy children. It can cause serious respiratory infections in young babies, especially those born prematurely, who have heart or lung disease, or who are immunocompromised.

74. Child Health Library - Infectious Diseases - Respiratory Syncytial Virus
    Information regarding respiratory syncytial virus and the complications it causes in babies from the Child Health Library of Children s Hospital of Pittsburgh.  
    http://www.chp.edu/greystone/infectious/rsv.php
    
    Extractions: About Parents Professionals Library ... Research Select Another Subject Adolescent Medicine Arthritis Burns Cardiovascular Disorders Craniofacial Anomalies Dermatology Eye Care Growth and Development High-Risk Newborn High-Risk Pregnancy Infectious Diseases Medical Genetics Mental Health Neurological Disorders Normal Newborn Oncology Orthopaedics Respiratory Disorders Surgery Terminally Ill, Care of Transplantation Urology About Pittsburgh Directions and Parking Departments and Services Find a Doctor ... Online Resources Respiratory Syncytial Virus (RSV) What is respiratory syncytial virus (RSV)? RSV is the most common cause of bronchiolitis (inflammation of the lower airways) and pneumonia in babies. It is an illness that often occurs in yearly outbreaks in communities and in newborn intensive care units (NICUs). In the United States, RSV is more common in winter and spring months. What causes respiratory syncytial virus (RSV)?

75. PRESS RELEASE: Respiratory Syncytial Virus (RSV) Is The Leading Cause Of Viral D
    Delivered by PRWEB Free Press Release Service) Research and Markets have announced the addition of the ‘respiratory syncytial virus Can Antivirals Make  
    http://www.prweb.com/releases/2004/4/prwebxml115275.php
    
    Extractions: All Press Releases for April 1, 2004 Respiratory Syncytial Virus (RSV) is the leading cause of viral death and respiratory tract infection (RTI) in children Research and Markets have announced the addition of the ‘Respiratory Syncytial Virus: Can Antivirals Make the Grade?’ report to their offering. (PRWEB) April 1, 2004 Respiratory Syncytial Virus (RSV) is the leading cause of viral death and respiratory tract infection (RTI) in children, and furthermore is a significant cause of morbidity in the elderly population. At present there is no effective vaccine or treatment against RSV infection, thereby constituting a considerable unmet medical need.

76. Respiratory Syncytial Virus
    respiratory syncytial virus. Author Timothy Paustian, Posted 9/11/00; 20606 PM. Topic respiratory syncytial virus. Msg 45 (top msg in thread).  
    http://www.bact.wisc.edu:8080/ScienceEd/discuss/msgReader$45
    
    Extractions: by Lindsey Monk Sunday, August 6, 2000 Respiratory Syncytial Virus (RSV) is one of the most common viruses, yet most people who have been affected by the virus never realize they are ill. However, this particular virus can cause severe lower respiratory illnesses such as bronchiolitis and pneumonia in infants, young children and the elderly. This virus can also have serious physiological effects on distinct groups our population, especially children who were born premature or who have immunodeficiency's, chronic lung conditions or congenital heart disease. This particular virus is very dangerous to young children because of their undeveloped immune system. However, it is known that two types of RSV, Type A and Type B, exist. Type B causes a mild upper respiratory infection that affects almost everybody and Type A is a severe lower respiratory tract infection that mainly affects infants, the elderly and those with a compromised immune system. Pathophysiologically, RSV attacks the bronchoalveolar epithelium, causing epithelial cell necrosis and an inflammatory response with a peri-bronchiolar infiltrate of lymphocytes, plasma cells and macrophages (Miller et al.,1999). The feeble or those with weak or compromised immunes systems are susceptible to the most severe form of RSV. Infants and children are at high risk for lower respiratory tract infections caused by the Type A virus. According to Miller et al. (1999), RSV is responsible for 45% to 75% of all cases of bronchiolities and pneumonia in infants and young children. During a child's first RSV infection, between 25% and 40% of infants and young children have signs or symptoms of bronchiolitis or pneumonia (National Center for Infectious Disease). RSV also tends to occur between six-weeks and two years of life. The severe Type A virus tends to occur in very young children who have a history of prematurity, congenital heart disease, chronic lung conditions or immunodeficiency. Other factors such as crowded unsanitary living conditions associated with low economic status, and exposure to cigarette smoke can increase the risk of being infected with RSV at a young age.

77. Respiratory Syncytial Virus
    respiratory syncytial virus. Previous topic Next topic respiratory syncytial virus, topic started 9/11/00; 20606 PM last post 9/11/00; 20606 PM.  
    http://www.bact.wisc.edu:8080/ScienceEd/discuss/msgReader$45?mode=topic

78. Nat'l Academies Press, Vaccines For The 21st Century: (2000), Appendix 20: Respi
    Reducing the Morbidity of Lower Respiratory Tract Infections Caused by respiratory syncytial virus .Still No Answer . respiratory syncytial virus.  
    http://books.nap.edu/openbook/0309056462/html/279.html
    
    Extractions: Openbook Linked Table of Contents Front Matter, pp. i-viii Contents, pp. ix-xii Executive Summary, pp. 1-10 Introduction, pp. 11-16 Progress in Vaccine Development, pp. 17-38 Considerations of Candidate Vaccines, pp. 39-52 Overview of Analytic Approach and Results, pp. 53-92 Review of the Analytical Model, pp. 93-108 Ethical Considerations and Caveats, pp. 109-122 Observations, pp. 123-132 References, pp. 133-142 Appendix 1: Borrelia burgdorferi , pp. 143-148 Appendix 2: Chlamydia, pp. 149-158 Appendix 3: Coccidioides Immitis , pp. 159-164 Appendix 4: Cytomegalovirus, pp. 165-172 Appendix 5: Enterotoxigenic E. coli , pp. 173-176 Appendix 6: Epstein-Barr Virus, pp. 177-180 Appendix 7: Helicobacter pylori , pp. 181-188

79. Pharmaceutical Research And Manufacturers Of America
    respiratory syncytial virus (RSV). Complete a new search There are no medicines for respiratory syncytial virus (RSV) listed in our database at this time.  
    http://www.phrma.org/newmedicines/newmedsdb/drugs.cfm?indicationcode=Respiratory

80. Pediatric Pharmacotherapy
    respiratory syncytial virus (RSV) is one of the most common viral pathogens known to man. Nearly all children have been infected by the age of two years.  
    http://www.people.virginia.edu/~smb4v/pedpharm/v3n10.htm
    
    Extractions: Volume 3, Number 10, September 1997 Prevention and Treatment of Respiratory Syncitial Virus - the search for a Cost-Effective Strategy Marcia L. Buck, Pharm.D. Formulary Update Respiratory syncytial virus (RSV) is one of the most common viral pathogens known to man. Nearly all children have been infected by the age of two years. Infection with RSV typically results in symptoms associated with a common cold. However, RSV may be a significant cause of morbidity and mortality in infants with underlying respiratory or cardiovascular disease, premature infants, immunocompromised patients, and the elderly. There are more than 90,000 annual hospitalizations in children for RSV lower respiratory tract infection. Two therapies for RSV are available in the United States. Ribavirin (Virazole ; ICN Pharmaceuticals) was approved in 1986 as a treatment for patients with RSV. Respiratory syncytial virus immune globulin (RespiGam

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

61-80 of 96    Back | 1  | 2  | 3  | 4  | 5  | Next 20